Stocktoria
Lyra Therapeutics, Inc. LYRA
OTC · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2020-05-01
Lyra Therapeutics, Inc. statistics & valuation
Market cap as of 2026-07-01. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Operating margin | -7794.5% | -6280.8% | -4308.1% | -4131.0% | -15303.5% | — | — |
| Net margin | -7266.1% | -6090.9% | -4023.1% | -4055.6% | -15267.7% | — | — |
| FCF margin | -7280.2% | -4716.4% | -4130.4% | -3195.1% | -10247.4% | — | — |
| Return on assets | -80.1% | -140.8% | -44.0% | -50.3% | -79.3% | -27.4% | -109.0% |
| Return on equity | 269.8% | -805.9% | -70.1% | -68.5% | -126.8% | -29.7% | 13.2% |
| Current ratio | 1.71 | 3.41 | 5.35 | 6.97 | 2.63 | 15.54 | 1.94 |
Source: SEC EDGAR filings · CIK 0001327273 · US · as of 2025-12-31. facts plus Stocktoria's own computed scores — not investment advice.